TL;DR
Researchers have discovered a novel cyclic peptide, epoxinnamide, from a marine-derived Streptomyces bacterium. This compound exhibits promising biological activities, including inducing quinone reductase (QR) and inhibiting angiogenesis, and its unique structure and biosynthesis offer insights into natural product drug discovery.
What Problem Does This Paper Address?
The vast majority of natural products with therapeutic potential are derived from terrestrial sources. However, marine environments, particularly mudflats, are rich and underexplored reservoirs of microbial diversity that can produce novel bioactive compounds. This paper addresses the challenge of identifying and characterizing new natural products from these marine environments, specifically focusing on the class of cinnamoyl-containing nonribosomal peptides (CCNPs), which are known for their diverse biological activities. The authors aim to discover a new CCNP, elucidate its complex structure and absolute configuration, and understand its biosynthetic origins and biological functions.
Methods
The researchers employed a multi-faceted approach:
- Isolation and Structure Elucidation: Standard techniques like liquid chromatography-mass spectrometry (LC/MS) were used to identify potential compounds. Nuclear Magnetic Resonance (NMR) spectroscopy (1D and 2D, including COSY, TOCSY, HSQC, and HMBC) and high-resolution electrospray ionization mass spectrometry (HRESIMS) were crucial for determining the molecular formula and connectivity of the new compound, epoxinnamide.
- Absolute Configuration Determination: A combination of advanced methods was used:
- Marfey's Method: This chemical derivatization technique followed by LC/MS analysis helps determine the stereochemistry of amino acid residues.
- 3JHH and ROESY NMR: These spectroscopic techniques provide information about through-bond and through-space proton-proton couplings, respectively, aiding in the determination of relative stereochemistry.
- DP4 Calculation: This computational method uses NMR data to predict and assign absolute configurations.
- Biosynthetic Pathway Analysis: Whole-genome sequencing of the producing Streptomyces strain was performed, and the resulting data was analyzed using the antiSMASH software to identify the biosynthetic gene cluster (BGC). This allowed for the prediction of the biosynthetic pathway and the identification of key enzymes.
- Bioactivity Assays: Standard cell-based assays were used to evaluate the biological activities of epoxinnamide:
- Quinone Reductase (QR) Assay: Measured the induction of QR activity in Hepa-1c1c7 murine hepatoma cells, a marker for chemopreventive effects.
- Antiangiogenesis Assay: Assessed the inhibition of tube formation in human umbilical vein endothelial cells (HUVECs), relevant for wound healing and diseases involving abnormal blood vessel growth.
Datasets
Not explicitly discussed as training or evaluation datasets in the context of machine learning. The primary "dataset" is the collection of secondary metabolites from 192 actinomycete strains isolated from an intertidal mudflat. The whole-genome sequence of Streptomyces sp. OID44 was generated and analyzed.
Key Insights and Ideas
- Marine Streptomyces as a Source of Novel Bioactives: This study reinforces the idea that marine environments, particularly mudflats, are a rich source of structurally unique and biologically active natural products, expanding the known chemical diversity beyond terrestrial sources.
- Epoxinnamide's Unique Structure: The discovery of epoxinnamide, a bicyclic deca-depsipeptide with an epoxy cinnamoyl (EPCA) acyl chain, highlights structural novelty within the CCNP family. The EPCA moiety itself is rare in nature.
- Bifunctional Thioesterase Domain: The identification of a unique bifunctional thioesterase domain within the NRPS BGC, capable of catalyzing both epimerization and macrocyclization, is a significant finding. This suggests an elegant mechanism for forming complex cyclic peptides.
- Structure-Activity Relationship (SAR) Clues: Comparing epoxinnamide to its close structural relative, nyuzenamide C, provides preliminary SAR insights. The substitution of certain amino acids (β-hydroxyleucine and threonine in epoxinnamide vs. β-hydroxyphenylalanine and valine in nyuzenamide C) appears to enhance QR-inducing activity while slightly reducing antiangiogenic effects.
Key Results
- Discovery of Epoxinnamide (1): A new CCNP was isolated and characterized.
- Structure Determination: The complete structure, including absolute configurations of amino acid residues and the EPCA moiety, was elucidated using a combination of spectroscopic and computational methods.
- Biosynthetic Pathway Proposed: The whole-genome sequencing and BGC analysis provided a putative biosynthetic pathway, identifying key NRPS modules and enzymes.
- Biological Activities:
- Epoxinnamide induced quinone reductase (QR) activity by 1.6-fold at 5 µM in Hepa-1c1c7 cells, showing stronger activity than nyuzenamide C.
- It exhibited effective antiangiogenesis activity with an IC50 of 13.4 µM in HUVECs, though slightly less potent than nyuzenamide C.
Limitations and Future Work
- Stereochemistry of Dht, Hgy, and Hpg: While some stereocenters were determined, the absolute configurations of the Dht, Hgy, and Hpg units required further investigation beyond standard spectroscopic analysis, which was addressed through genomic analysis.
- EPCA Moiety Formation: The precise mechanism for the formation of the benzene ring within the EPCA moiety was not fully elucidated and requires further research.
- Mechanism of Action: While bioactivities were demonstrated, the specific molecular mechanisms underlying QR induction and antiangiogenesis are not detailed and represent avenues for future investigation.
- Broader Bioactivity Screening: Further exploration of epoxinnamide's bioactivity against other targets and in different biological systems would be valuable.
- Synthetic Elaboration: The synthesis of epoxinnamide or its analogs could provide more definitive SAR data and access to larger quantities for further studies.
Summary updated